Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIME: IqYmune vs Kiovig in Multifocal Motor Neuropathy
NCT01951924Phase 3Completed
- Sponsor
- LFB Group
- Start
- Dec 2013
- Primary completion
- Jul 2016
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 3 trial of IqYmune in multifocal motor neuropathy (MMN), sponsored by LFB Group. Started Dec 2013; status: completed.
02
Drugs
IqYmune
03
Conditions
multifocal motor neuropathy (MMN)
Beyond the preview
Go deeper on NCT01951924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01951924.